DENTSPLY SIRONA Inc. to Post FY2017 Earnings of $2.67 Per Share, William Blair Forecasts (NASDAQ:XRAY)

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Analysts at William Blair cut their FY2017 EPS estimates for DENTSPLY SIRONA in a note issued to investors on Wednesday. William Blair analyst J. Kreger now anticipates that the medical instruments supplier will post earnings per share of $2.67 for the year, down from their previous forecast of $2.83. William Blair also issued estimates for DENTSPLY SIRONA’s FY2018 earnings at $2.90 EPS.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share for the quarter, hitting the consensus estimate of $0.65. The company had revenue of $992.70 million during the quarter, compared to analysts’ expectations of $1 billion. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The business’s quarterly revenue was down 2.9% on a year-over-year basis. During the same period last year, the business earned $0.76 EPS.

COPYRIGHT VIOLATION WARNING: This piece was reported by Community Financial News and is the property of of Community Financial News. If you are reading this piece on another domain, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this piece can be read at https://www.com-unik.info/2017/08/12/dentsply-sirona-inc-to-post-fy2017-earnings-of-2-67-per-share-william-blair-forecasts-nasdaqxray.html.

Several other equities research analysts also recently commented on XRAY. Zacks Investment Research upgraded DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a report on Wednesday, April 19th. Goldman Sachs Group, Inc. (The) downgraded DENTSPLY SIRONA from a “neutral” rating to a “sell” rating and decreased their price objective for the company from $60.00 to $55.00 in a report on Tuesday, May 23rd. Cleveland Research upgraded DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a report on Tuesday, May 23rd. BidaskClub downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Saturday, June 10th. Finally, HC Wainwright initiated coverage on DENTSPLY SIRONA in a report on Tuesday, July 11th. They set a “buy” rating and a $74.00 price objective for the company. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and nine have given a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $66.75.

DENTSPLY SIRONA (XRAY) opened at 55.33 on Friday. The company’s market capitalization is $12.69 billion. DENTSPLY SIRONA has a 52 week low of $54.49 and a 52 week high of $65.68. The stock’s 50 day moving average is $62.91 and its 200 day moving average is $62.30.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. BlackRock Inc. increased its position in shares of DENTSPLY SIRONA by 3,103.7% in the first quarter. BlackRock Inc. now owns 13,891,329 shares of the medical instruments supplier’s stock worth $867,376,000 after buying an additional 13,457,730 shares during the period. Principal Financial Group Inc. increased its position in shares of DENTSPLY SIRONA by 1,445.2% in the first quarter. Principal Financial Group Inc. now owns 5,292,885 shares of the medical instruments supplier’s stock worth $330,488,000 after buying an additional 4,950,337 shares during the period. Clearbridge Investments LLC increased its position in shares of DENTSPLY SIRONA by 34.6% in the first quarter. Clearbridge Investments LLC now owns 5,258,060 shares of the medical instruments supplier’s stock worth $328,313,000 after buying an additional 1,353,040 shares during the period. Point72 Asset Management L.P. acquired a new position in shares of DENTSPLY SIRONA during the first quarter worth about $64,184,000. Finally, Renaissance Technologies LLC increased its position in shares of DENTSPLY SIRONA by 246.0% in the first quarter. Renaissance Technologies LLC now owns 1,044,558 shares of the medical instruments supplier’s stock worth $65,222,000 after buying an additional 742,700 shares during the period. Hedge funds and other institutional investors own 95.17% of the company’s stock.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 13th. Shareholders of record on Friday, September 29th will be paid a $0.0875 dividend. The ex-dividend date is Thursday, September 28th. This represents a $0.35 dividend on an annualized basis and a yield of 0.63%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -10.09%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

What are top analysts saying about DENTSPLY SIRONA Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for DENTSPLY SIRONA Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit